|
1
|
Stojan G and Petri M: Epidemiology of
systemic lupus erythematosus: An update. Curr Opin Rheumatol.
30:144–150. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghodke-Puranik Y and Niewold TB:
Immunogenetics of systemic lupus erythematosus: A comprehensive
review. J Autoimmun. 64:125–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Quintero OL, Amador-Patarroyo MJ,
Montoya-Ortiz G, Rojas-Villarraga A and Anaya JM: Autoimmune
disease and gender: Plausible mechanisms for the female
predominance of autoimmunity. J Autoimmun. 38:J109–J119. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barbhaiya M and Costenbader KH:
Environmental exposures and the development of systemic lupus
erythematosus. Curr Opin Rheumatol. 28:497–505. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barbhaiya M and Costenbader KH:
Ultraviolet radiation and systemic lupus erythematosus. Lupus.
23:588–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernatsky S, Fournier M, Pineau CA, Clarke
AE, Vinet E and Smargiassi A: Associations between ambient fine
particulate levels and disease activity in patients with systemic
lupus erythematosus (SLE). Environ Health Perspect. 119:45–49.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zandman-Goddard G and Shoenfeld Y:
Infections and SLE. Autoimmunity. 38:473–485. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Yin Y, Zhang E, Zhu G, Liu M,
Feng L, Qin B and Liu X: Spectral attenuation of ultraviolet and
visible radiation in lakes in the Yunnan Plateau, and the middle
and lower reaches of the Yangtze River, China. Photochem Photobiol
Sci. 10:469–482. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong H, Li XL, Li M, Hao LX, Chen RW,
Xiang K, Qi XB, Ma RZ and Su B: Replicated associations of TNFAIP3,
TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern
Chinese population. Arthritis Res Ther. 13:R1862011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian G, Ran X, Zhou CX, Deng DQ, Zhang PL,
Guo Y, Luo JH, Zhou XH, Xie H and Cai M: Systemic lupus
erythematosus patients in the low-latitude plateau of China:
Altitudinal influences. Lupus. 23:1537–1545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dominguez-Gutierrez PR, Ceribelli A, Satoh
M, Sobel ES, Reeves WH and Chan EK: Reduced levels of CCL2 and
CXCL10 in systemic lupus erythematosus patients under treatment
with prednisone, mycophenolate mofetil, or hydroxychloroquine,
except in a high STAT1 subset. Arthritis Res Ther. 16:R232014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crow MK: Type I interferon in the
pathogenesis of lupus. J Immunol. 192:5459–5468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Antonelli A, Ferrari SM, Giuggioli D,
Ferrannini E, Ferri C and Fallahi P: Chemokine (C-X-C motif) ligand
(CXCL)10 in autoimmune diseases. Autoimmun Rev. 13:272–280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bruck P, Bartsch W, Penna-Martinez M,
Kahles H, Seidl C, Böhme A, Badenhoop K and Ramos-Lopez E:
Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. Hum
Immunol. 70:552–555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruffilli I, Ferrari SM, Colaci M, Ferri C,
Fallahi P and Antonelli A: IP-10 in autoimmune thyroiditis. Horm
Metab Res. 46:597–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauer JW, Petri M, Batliwalla FM, Koeuth
T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK,
Behrens TW and Baechler EC: Interferon-regulated chemokines as
biomarkers of systemic lupus erythematosus disease activity: A
validation study. Arthritis Rheum. 60:3098–3107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reynolds JA, McCarthy EM, Haque S,
Ngamjanyaporn P, Sergeant JC, Lee E, Lee E, Kilfeather SA, Parker B
and Bruce IN: Cytokine profiling in active and quiescent SLE
reveals distinct patient subpopulations. Arthritis Res Ther.
20:1732018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
O'Leary NA, Wright MW, Brister JR, Ciufo
S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B,
Ako-Adjei D, et al: Reference sequence (RefSeq) database at NCBI:
Current status, taxonomic expansion, and functional annotation.
Nucleic Acids Res. 44:D733–D745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hinrichs AS, Raney BJ, Speir ML, Rhead B,
Casper J, Karolchik D, Kuhn RM, Rosenbloom KR, Zweig AS, Haussler D
and Kent WJ: UCSC data integrator and variant annotation
integrator. Bioinformatics. 32:1430–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aken BL, Ayling S, Barrell D, Clarke L,
Curwen V, Fairley S, Fernandez Banet J, Billis K, García Girón C,
Hourlier T, et al: The Ensembl gene annotation system. Database
(Oxford). 2016(pii): baw0932016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Díaz-Montaña JJ, Gómez-Vela F and
Díaz-Díaz N: GNC-app: A new Cytoscape app to rate gene networks
biological coherence using gene-gene indirect relationships.
Biosystems. 166:61–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Foster MH: T cells and B cells in lupus
nephritis. Semin Nephrol. 27:47–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bruck P, Bartsch W, Sadet D,
Penna-Martinez M, Kurylowicz A, Bednarczuk T, Robbers I, Paunkovic
J, Böhme A, Badenhoop K and Ramos-Lopez E: A CXC motif ligand 10
polymorphism as a marker to predict severity of Graves' disease.
Thyroid. 20:343–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Li M, Wang Y, Xu D, Wang Q, Zhang
S, Zhao J, Su J, Wu Q, Shi Q, et al: Long-term mortality and
morbidity of patients with systemic lupus erythematosus: A
single-center cohort study in China. Lupus. 27:864–869. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kemp MG, Lindsey-Boltz LA and Sancar A: UV
light potentiates STING (Stimulator of Interferon Genes)-dependent
innate immune signaling through deregulation of ULK1 (Unc51-like
Kinase 1). J Biol Chem. 290:12184–12194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Olson JK, Croxford JL and Miller SD:
Virus-induced autoimmunity: Potential role of viruses in
initiation, perpetuation and progression of T-cell-mediated
autoimmune disease. Viral immunol. 14:227–250. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng D and Barnes BJ: Bioinformatics
analysis of the factors controlling type I IFN gene expression in
autoimmune disease and virus-induced immunity. Front Immunol.
4:2912013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Becker AM, Dao KH, Han BK, Kornu R,
Lakhanpal S, Mobley AB, Li QZ, Lian Y, Wu T, Reimold AM, et al: SLE
peripheral blood B cell, T cell and myeloid cell transcriptomes
display unique profiles and each subset contributes to the
interferon signature. PLoS One. 8:e670032013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ronnblom L and Alm GV: Systemic lupus
erythematosus and the type I interferon system. Arthritis Res Ther.
5:68–75. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garcia-Sastre A and Biron CA: Type 1
interferons and the virus-host relationship: A lesson in detente.
Science. 312:879–882. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawai T and Akira S: Innate immune
recognition of viral infection. Nat Immunol. 7:131–137. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Ni J, Li LJ, Leng RX, Pan HF and Ye
DQ: Decreased UBASH3A mRNA expression levels in peripheral blood
mononuclear cells from patients with systemic lupus erythematosus.
Inflammation. 38:1903–1910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bauer JW, Petri M, Batliwalla FM, Koeuth
T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK,
Behrens TW and Baechler EC: Interferon-regulated chemokines as
biomarkers of systemic lupus erythematosus disease activity: A
validation study. Arthritis Rheum. 60:3098–3107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rose T, Grutzkau A, Hirseland H, Huscher
D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P,
Radbruch A, et al: IFNα and its response proteins, IP-10 and
SIGLEC-1, are biomarkers of disease activity in systemic lupus
erythematosus. Ann Rheum Dis. 72:1639–1645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Oke V, Brauner S, Larsson A, Gustafsson J,
Zickert A, Gunnarsson I and Svenungsson E: IFN-λ1 with Th17 axis
cytokines and IFN-α define different subsets in systemic lupus
erythematosus (SLE). Arthritis Res Ther. 19:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee HT, Wu TH, Lin CS, Lee CS, Pan SC,
Chang DM, Wei YH and Tsai CY: Oxidative DNA and mitochondrial DNA
change in patients with SLE. Front Biosci (Landmark Ed).
22:493–503. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Narumi S, Takeuchi T, Kobayashi Y and
Konishi K: Serum levels of IFN-inducible protein-10 relating to the
activity of systemic lupus erythematosus. Cytokine. 12:1561–1565.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu M, Guo S, Hibbert JM, Jain V, Singh N,
Wilson NO and Stiles JK: CXCL10/IP-10 in infectious diseases
pathogenesis and potential therapeutic implications. Cytokine
Growth Factor Rev. 22:121–130. 2011.PubMed/NCBI
|
|
43
|
Touzot M, Cacoub P, Bodaghi B, Soumelis V
and Saadoun D: IFN-α induces IL-10 production and tilt the balance
between Th1 and Th17 in Behçet disease. Autoimmun Rev. 14:370–375.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mezger M, Steffens M, Beyer M, Manger C,
Eberle J, Toliat MR, Wienker TF, Ljungman P, Hebart H, Dornbusch
HJ, et al: Polymorphisms in the chemokine (C-X-C motif) ligand 10
are associated with invasive aspergillosis after allogeneic
stem-cell transplantation and influence CXCL10 expression in
monocyte-derived dendritic cells. Blood. 111:534–536. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Deng GM and Tsokos GC: Pathogenesis and
targeted treatment of skin injury in SLE. Nat Rev Rheumatol.
11:663–669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wahren-Herlenius M and Dörner T:
Immunopathogenic mechanisms of systemic autoimmune disease. Lancet.
382:819–831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Holder A, Jones G, Soutter F, Palmer DB,
Aspinall R and Catchpole B: Polymorphisms in the canine IL7R 3′UTR
are associated with thymic output in Labrador retriever dogs and
influence post-transcriptional regulation by microRNA 185. Dev Comp
Immunol. 81:244–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu X, Wang L, Chi H, Wang J, Zheng Q, Li
J, Li Y and Yang D: The SNP Rs915014 in MTHFR regulated by MiRNA
associates with atherosclerosis. Cell Physiol Biochem.
45:1149–1155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wilson N, Driss A, Solomon W,
Dickinson-Copeland C, Salifu H, Jain V, Singh N and Stiles J:
CXCL10 gene promoter polymorphism-1447A>G correlates with plasma
CXCL10 levels and is associated with male susceptibility to
cerebral malaria. PLoS One. 8:e813292013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Deng G, Zhou G, Zhang R, Zhai Y, Zhao W,
Yan Z, Deng C, Yuan X, Xu B, Dong X, et al: Regulatory
polymorphisms in the promoter of CXCL10 gene and disease
progression in male hepatitis B virus carriers. Gastroenterology.
134:716–726. 2008. View Article : Google Scholar : PubMed/NCBI
|
